Henry Heinsohn
Vice President, Technology and Innovation
Biopharmaceuticals
Sutro Biopharma
United States of America
Biography
Mr. Heinsohn has over 24 years of process development and manufacturing experience related to recombinant protein production. He came to Sutro after working at Genentech for 17 years, where he held the role of Senior Scientist and Senior Group Leader for process development, early stage purification activities. While at Genentech, he developed large-scale protein recovery processes, supported research and development activities and participated in regulatory filings for VEGF, thrombopoeitin, Lucentis, and other novel protein therapeutics. He was CMC team leader for the development and launch of Avastin. Prior to joining Genentech, Henry was employed by Genencor International where he was Senior Scientist. Previously, he was a scientist at Corning Medical and Scientific. Henry received a B.S. in Chemistry from North Carolina State University, and conducted postgraduate studies in Biochemistry at the Boston University.
Research Interest
recombinant protein production